Liver Reference Set Application (Full): Block - Drexel Univ (2010)
The goal of this application is to determine if the levels of serum GP73 and fucosylated kininogen/acute phase proteins can be used to detect hepatocellular carcinoma (HCC) in the background of liver cirrhosis. The use of the validation set would allow us to directly compare GP73 and fucosylated markers against AFP, AFP-L3 and DCP as well as test them in combination with these markers
There are currently no biomarkers annotated for this protocol.
No datasets are currently associated with this protocol.